Biomarkers in two different animal models of pulmonary arterial hypertension (PAH) under treatment with a cGMP enhancing substance

相似書籍

• Impaired NO-cGMP signaling in the pathogenesis of neonatal pulmonary hypertension and therapeutic implications
  由: Abman, Steve H
  出版: (2009)
• Negative feedback regulation within NO/cGMP pathway attenuates vasodilatory response in renovascular hypertension
  由: Mergia, Evanthia, et al.
  出版: (2009)
• Urinary cGMP concentrations in severe primary pulmonary hypertension
  由: Bogdan, M., et al.
  出版: (1998)
• Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension
  由: Chester, Marc, et al.
  出版: (2011)
• cGMP : generators, effectors and therapeutic implications
  由: Schmidt, Harald H. H. W., et al.
  出版: (2009)